The estimated Net Worth of Emily Peterson Alva is at least $599 Tausend dollars as of 29 June 2024. Ms. Alva owns over 6,104 units of Amneal Pharmaceuticals Inc stock worth over $240,492 and over the last 7 years she sold AMRX stock worth over $0. In addition, she makes $358,843 as Independent Director at Amneal Pharmaceuticals Inc.
Emily has made over 12 trades of the Amneal Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 6,104 units of AMRX stock worth $51,029 on 29 June 2024.
The largest trade she's ever made was exercising 80,128 units of Amneal Pharmaceuticals Inc stock on 9 May 2023 worth over $669,870. On average, Emily trades about 13,898 units every 76 days since 2018. As of 29 June 2024 she still owns at least 28,767 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Ms. Alva stock trades at the bottom of the page.
Emily Peterson Alva serves as Independent Director of the Company. Ms. Alva is a financial, strategic and business advisor to senior executives, founders and corporate boards of directors, and has focused on private company advisory projects and family office investing since 2013. Prior to that time, Ms. Alva spent more than 15 years at Lazard as a senior mergers & acquisitions investment banker advising industry leading companies. Ms. Alva’s extensive advisory and transaction work covers multiple industries with a primary sector focus and expertise in healthcare. While at Lazard, Ms. Alva held leadership roles, both with clients and internally. She advised some of Lazard’s most important clients over many years, and was one of the youngest bankers promoted to Managing Director at the firm. During her Lazard tenure, Ms. Alva was selected for the Council on Foreign Relations’ Corporate Leaders Program, which recognizes accomplished professionals on a senior management track and links business leaders with decision makers in government and academia. Prior to joining Lazard, Ms. Alva worked at a development stage company focused on engineering-based solutions to improve industrial waste processing systems. More recently, Ms. Alva has served as a Board Member and Treasurer for the Alumnae Board of Directors of Barnard College. Ms. Alva received a BA in Economics from Barnard College, Columbia University
As the Independent Director of Amneal Pharmaceuticals Inc, the total compensation of Emily Alva at Amneal Pharmaceuticals Inc is $358,843. There are 9 executives at Amneal Pharmaceuticals Inc getting paid more, with Andrew Boyer having the highest compensation of $3,113,080.
Emily Alva is 45, she's been the Independent Director of Amneal Pharmaceuticals Inc since 2018. There are 19 older and 2 younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
Emily's mailing address filed with the SEC is CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN, , 4 Ireland.
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc und International Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: